Revolution Medicines RVMD Cash Flow Statement (2019-2026)

NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT
Reported Financials

Revolution Medicines Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Revolution Medicines reported cash from operations of -$387.32M and free cash flow of -$389.61M for the quarter ended Jun 2026, down 74.7% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-52.94M-52.68M-57.65M-61.22M-73.33M-56.51M-68.10M-98.30M-108.43M-161.54M-116.00M-133.23M-156.29M-194.57M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Depreciation and DepletionDep. & Depletion
0.90M0.90M1.00M1.18M1.21M1.20M1.30M1.30M1.50M1.60M1.60M1.40M1.60M1.70M2.00M2.10M2.20M2.10M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.30M0.10M
Depreciation & Amortization (CF)Dep. & Amort.
0.79M0.83M0.90M0.93M0.99M1.15M1.21M1.22M1.30M1.30M1.54M1.64M1.64M1.74M1.69M2.29M1.53M2.27M2.35M2.45M
Share-based CompensationStock Comp.
5.83M6.20M6.64M8.10M8.14M8.32M9.70M12.98M13.67M25.43M16.21M19.78M20.78M22.44M25.08M28.83M30.78M33.70M87.30M67.00M
Deferred Taxes
-0.12M-0.04M-0.76M
Gains from Sales and DivestituresGains Divest
-0.10M-0.02M-0.02M0.00M-0.05M-0.07M-0.04M-0.20M0.20M-0.03M
Asset Writedowns and ImpairmentWritedown
2.76M
Other non-cash itemsOther Non-Cash
0.69M0.98M1.12M1.14M1.18M1.18M1.06M0.28M0.61M1.36M-2.95M-1.02M2.24M1.61M-0.68M4.58M14.03M26.93M30.17M151.03M
Change in Working Capital
Change in ReceivablesChange Receivables
0.89M-1.48M-0.55M0.24M-0.68M-0.27M-0.68M-1.49M-2.20M0.95M-1.25M
Change in Account PayablesChange Payables
0.19M2.57M-0.49M-0.95M10.24M-1.51M-1.05M8.63M0.58M24.31M-28.96M-4.08M-2.79M29.36M-8.27M8.76M19.55M-10.50M16.86M5.03M
Change in Accured ExpensesChange Accured Exp.
1.73M3.74M-2.11M7.88M-1.30M-2.97M-1.75M15.13M7.58M-6.29M-21.26M14.67M10.28M18.30M1.55M10.82M45.29M54.60M-16.74M55.78M
Change in Other Operating AssetsOther Assets Change
-0.69M-0.72M3.53M5.71M-0.68M-2.54M-1.70M1.05M9.54M-4.83M0.47M12.48M-2.48M5.10M-6.99M12.40M18.32M10.83M21.03M38.29M
Change in Other Operating LiabilitiesOther Liabilities Change
6.05M-4.27M-1.52M-5.93M2.17M-11.81M-2.53M-2.93M0.32M-0.70M2.22M-2.85M0.37M0.23M1.97M0.75M-2.11M-1.03M3.59M-7.36M
Other Working Capital ChangesOther WC Changes
6.74M-3.55M-5.05M-11.64M2.85M-9.28M-0.83M-3.98M-9.22M4.13M1.75M-15.33M2.85M-4.88M8.96M-11.65M-20.43M-11.86M-17.44M-45.64M
Cash from OperationsCash from Ops.
-36.59M-39.27M-55.16M-55.72M-51.74M-61.79M-62.39M-67.12M-100.50M-120.56M-160.56M-128.17M-130.42M-138.29M-194.44M-221.76M-207.31M-274.24M-354.17M-387.32M
Investing Activities
Capital ExpendituresCapex
0.45M1.18M1.89M2.53M3.53M2.88M1.76M1.12M2.54M2.32M3.17M2.40M3.52M1.22M3.27M7.45M3.35M1.93M1.54M2.29M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.45M-1.18M-1.89M-2.53M-3.53M-2.88M-1.76M-1.12M-2.54M-2.32M-3.17M-2.40M-3.52M-1.22M-3.27M-7.45M-3.35M-1.93M-1.54M-2.29M
Purchase of InvestmentsInvestments Purchased
168.25M110.81M111.82M127.65M212.96M160.34M193.10M176.18M170.04M519.61M701.68M374.86M364.88M695.21M510.04M529.29M459.04M296.49M209.73M2,038.36M
Sale and Maturity of InvestmentsInvestments Sold
138.53M120.53M157.73M192.58M93.05M156.11M198.85M133.75M249.93M141.52M456.88M485.20M346.93M303.53M497.35M571.02M487.24M373.29M383.89M381.98M
Cash from Investing ActivitiesCash from Investing
-30.18M8.53M44.03M62.40M-123.44M-7.10M4.00M-43.54M77.35M-380.40M-247.97M107.94M-21.47M-392.90M-15.95M34.28M24.85M74.88M172.62M-1,658.67M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.32M1.06M0.31M1.43M248.34M1.40M1.01M2.55M0.81M7.50M3.00M829.09M0.89M6.58M4.15M17.55M12.27M1,688.91M
Net Shares Issued and RepurchasedNet Shares Issued
0.32M1.06M0.31M1.43M248.34M1.40M1.01M2.55M0.81M7.50M3.00M829.09M0.89M6.58M4.15M17.55M12.27M1,688.91M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.32M1.06M0.31M1.43M248.34M1.40M1.01M2.55M0.81M7.50M3.00M829.09M0.89M6.58M4.15M17.55M12.27M1,688.91M
Other financing activitiesOther financing
0.28M-0.02M0.00M0.05M0.19M-0.25M-0.49M
Cash from Financing ActivitiesCash from Financing
0.32M10.73M0.31M1.43M248.34M51.36M324.21M64.63M1.01M839.35M0.81M7.50M77.29M873.81M0.87M256.58M-1.59M365.66M238.74M2,420.49M
Additional items
Change in Cash
-66.45M-20.00M-10.83M8.11M73.16M-17.53M265.81M-46.04M-22.13M338.39M-407.72M-12.72M-74.59M342.61M-209.51M69.10M-184.05M166.30M57.19M374.50M
Ending Cash Balance
130.24M110.23M99.40M107.52M180.68M163.15M428.96M382.92M360.79M699.18M291.46M278.74M204.15M546.76M337.25M406.35M222.30M388.60M445.80M820.29M
Free Cash FlowFCF
-37.04M-40.45M-57.05M-58.24M-55.26M-64.66M-64.15M-68.24M-103.03M-122.88M-163.73M-130.57M-133.94M-139.51M-197.70M-229.21M-210.66M-276.16M-355.70M-389.61M
Net Cash FlowNCF
-66.45M-20.00M-10.83M8.11M73.16M-17.53M265.81M-46.04M-22.13M338.39M-407.72M-12.72M-74.59M342.61M-209.51M69.10M-184.05M166.30M57.19M374.50M

Revolution Medicines Cash Flow Statement API

Pull Revolution Medicines's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RVMD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY